Skip to main content
search
All Posts By

admin

Consultations Archive

Consultation on the diagnosis and management of type 1 diabetes in adults

A new consultation concerning the diagnosis and management of type 1 diabetes in adults has been launched by NICE following a review of current evidence. A number of existing recommendations on diagnosis and continuous glucose management have been replaced. Other recommendations have been moved or updated to reflect these alterations. If you wish to respond, please submit your feedback here…
admin
November 26, 2021
Consultations Archive

Consultation on glucose monitoring in children and young people with diabetes (type 1 and type 2)

NICE has issued a consultation on glucose monitoring in children and young people with diabetes (type 1 and 2) following a review of the latest evidence. Existing recommendations pertaining to continuous glucose monitoring have been replaced by new recommendations, while other recommendations have been updated to reflect these changes. Members are encouraged to respond to this consultation here (https://www.nice.org.uk/guidance/indevelopment/gid-ng10266/consultation/html-content) before…
admin
November 26, 2021
Consultations Archive

Consultation on Type 2 diabetes in adults: management – glucose monitoring

BIVDA is seeking input from members regarding NICE’s consultation on glucose monitoring in adults with type 2 diabetes. The consultation specifically concerns the addition of new recommendations on continuous glucose monitoring for adults with type 2 diabetes following a review of the latest evidence. Other recommendations have been updated to reflect these changes. The consultation can be found here (https://www.nice.org.uk/guidance/indevelopment/gid-ng10264/consultation/html-content).…
admin
November 26, 2021
Membership NewsMembership News Archive

LifeArc pledges £1.3 billion by 2030 to establish new medical innovations

This represents a doubling of LifeArc’s annual spend – a significant boost to the UK life sciences sector – and signals the charity’s intention to play a key role in establishing the UK as a global life sciences superpower. The charity has been noted as an early-stage translation specialist and seeks to accelerate scientific advances in order to bring preventative…
admin
November 26, 2021
HighlightsHighlights Archive

Government to publish MedTech strategy in first half of 2022

The proposal was disclosed after Labour MP Rosie Cooper asked whether the Secretary of State planned to increase funding available via the MedTech Funding Mandate. Mr Argar also revealed that the Department intends to work with industry on a range of approaches to “tackle the underlying causes of the lack of adoption” as part of the strategy. The plan will…
admin
November 26, 2021
HighlightsHighlights Archive

AstraZeneca opens The Discovery Centre in Cambridge

The move will bolster AstraZeneca’s efforts to develop cutting-edge therapeutics, such as nucleotide-based gene-editing and cell therapies, and support their focus on specialised and precision medicines. The company hopes that the unveiling marks a new wave of scientific innovation for the UK. It also puts the UK’s world-class life sciences cluster in Cambridge, which generates almost £3 billion annually to…
admin
November 26, 2021
Membership NewsMembership News ArchiveProcurement Working PartyProcurement Working Party Archive

BIVDA is pleased to announce a working partnership with IntelliCentrics UK

This partnership is a sector leading initiative, intended to simplify the process which is becoming increasingly prominent in Trusts. Working closely with NHS and Private hospitals through Intellicentrics, BIVDA will be able to support members to conduct their business in customer accounts with appropriate entry criteria relative to the job roles they perform, Credentialling is important for hospitals and patients…
admin
November 26, 2021
Membership NewsMembership News Archive

BIVDA response submitted to MHRA UKCA consultation

The consolidated BIVDA response to the MHRA consultation on the future regulation of medical devices in the United Kingdom was submitted on 25 November. This was a full response to all sections relevant to IVDs, and was based on feedback provided by members. BIVDA have also drafted a cover letter to be provided to MHRA separately, supplementing the information provided…
admin
November 26, 2021
HighlightsHighlights Archive

Health and Care Bill passes House of Commons stages

The Health and Care Bill went through its remaining stages in the House of Commons this week. Amendments were made to the Bill regarding some of the following areas: the workforce in the health service or related sectors, cosmetic procedures, virginity testing or hymenoplasty, and clauses relating to the Health Services Safety Investigations Body. Branding of e-cigarettes was also debated…
admin
November 26, 2021
Close Menu